Palomar Holdings, Inc. Key Metrics

2 years of history · ending 2025-12-31 · SEC EDGAR

Per Share Metrics

Expense Ratios

Working Capital Analysis

Valuation Multiples

Cash-Flow Multiples

Enterprise Value Multiples

52-Week Range

Trailing Returns

Yields

Capital Deployment Yields

Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)

EPS (Diluted)
$7
Book Value Per Share
$34
Free Cash Flow Per Share
$15
Cash Per Share
$4
Revenue Per Share
$32
OCF Per Share
$15
Return on Equity
23.6%
Return on Assets
7.4%
Asset Turnover
0.33
SBC / Revenue
2.4%
Capex / Revenue
0.0%
Invested Capital
$943M
OCF / Net Income
2.08
FCF / Net Income
2.08
Accruals Ratio (Sloan)
-7.0%
Net Debt
$-107M
Net Debt / EBITDA
-11.97
Cash Coverage
1043.68
Capex Coverage
2986.28
Tangible Common Equity
$912M
TCE / Total Assets
29.9%
Goodwill / Total Assets
1.0%
Cash ROIC
48.9%
Capex / D&A
0.02
Total Payout Ratio
18.9%
Asset Growth vs Revenue Growth
-23.3%
Revenue 5Y CAGR
39.1%
EPS 5Y CAGR
99.4%
FCF 5Y CAGR
48.1%
EBITDA 5Y CAGR
46.2%
Book Value 5Y CAGR
21.0%
Stock Price (FY-end)
$135
Market Cap
$3.70B
P/E Ratio
18.79
P/S Ratio
4.23
P/B Ratio
3.93
P/TB Ratio
4.06
P/OCF Ratio
9.05
P/FCF Ratio
9.06
Enterprise Value
$3.60B
EV / EBITDA
402.94
EV / Sales
4.11
EV / FCF
8.80
FCF Yield
11.0%
Shareholder Yield
0.4%
Buyback Yield
1.0%
Capex Yield
0.0%
Graham Number
$74
Shares Variation (YoY)
4.8%
Beta (5Y)
0.99
Cost of Equity
9.4%
52W High
$176
52W Low
$102
Trailing Return 1Y
29.1%
Trailing Return 5Y
47.1%

Earnings Forecasts

Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).

Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.

EPS — Consensus vs Actual

Revenue — Consensus vs Actual

Stock Price on Earnings Dates

Palomar Holdings, Inc. — Effective Tax Rate ReconciliationNEW

Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.

Effective Rate Trend

Reconciliation LineFY2020FY2021FY2022FY2023FY2024FY2025
Federal Statutory Rate21.00%21.00%21.00%21.00%21.00%21.00%
State & Local Income Taxes-3.06%1.14%0.69%0.32%0.41%
Foreign Rate Differential
Other Adjustments-5.67%-0.18%0.00%0.26%0.50%0.45%
SBC (Nondeductible)-24.44%-1.87%0.23%1.47%0.28%0.22%
Valuation Allowance Change9.63%3.85%-0.28%-0.40%0.08%0.04%
Tax Law Change
Effective Tax Rate-0.54%19.76%22.77%23.58%22.23%22.22%

Cash vs Accrual

ItemFY2020FY2021FY2022FY2023FY2024FY2025
Income Tax Expense (Accrual)−$34.0K$11.3M$15.4M$24.4M$33.6M$56.3M
Income Taxes Paid (Cash)$7.2M$2.1M$18.9M$21.1M$38.5M$59.1M

Palomar Holdings, Inc. — M&A AcquisitionsNEW

Per-deal acquisition disclosures sourced from us-gaap:BusinessAcquisitionAxis dimensional XBRL. Each card surfaces the deal's purchase-price allocation (goodwill vs intangibles vs liabilities), contingent consideration (unpaid earn-outs), and pro-forma combined-entity numbers. Probability-of-Success (PoS) factor on biotech targets is the ASC 805 contingent-consideration valuation — higher = closer to commercialization, higher implied target value.

Advanced Ag Protection LLC

Total Consideration

$32.5M

Purchase-Price Allocation

Goodwill

$21.8M

First Indemnity Of America Insurance Company

Total Consideration

$29.5M

Purchase-Price Allocation

Goodwill

$4.9M

Gray Casualty And Surety Company

Total Consideration

$311.0K

Palomar Holdings, Inc. — Litigation CasesNEW

Per-case litigation disclosures sourced from us-gaap:LossContingenciesByNatureOfContingencyAxis dimensional XBRL. Coverage is sparse — most filers aggregate at the parent level (JNJ talc, PFE opioid) — but high-value when per-case disclosure exists. Loss estimate is either a single point or a low/high range, depending on how the issuer values the contingency.

As of 2025-12-31

CaseEstimated LossDamages SoughtSettlement
Standby Letters Of Credit$4M